For the year ending 2025-12-31, VSEE has $22,413,019 in assets. $16,960,651 in debts. $5,266,286 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Cash | 5,266,286 | 326,115 | ||
| Accounts receivable, net of allowance for credit losses of 835,007 and 2,393,033 as of december 31, 2025, and 2024, respectively | 2,520,844 | 1,716,370 | ||
| Due from related party | 304,614 | 531,656 | ||
| Prepaids and other current assets | 273,663 | 446,826 | ||
| Total current assets | 8,365,407 | 3,020,967 | ||
| Right-of-use assets, net | 13,304 | 379,585 | ||
| Intangible assets, net | 8,785,000 | 10,995,000 | ||
| Goodwill | 4,916,694 | 4,916,694 | ||
| Fixed assets, net | 332,614 | 680,242 | ||
| Total assets | 22,413,019 | 19,992,488 | ||
| Accounts payable and accrued liabilities | 11,536,775 | 9,343,659 | ||
| Deferred revenue | 1,324,485 | 417,815 | ||
| Due to related parties | 51,900 | 51,900 | ||
| Operating lease liabilities | 10,394 | 72,836 | ||
| Financing lease liabilities | 131,062 | 328,833 | ||
| Factoring payable | 0 | 179,007 | ||
| Encompass purchase liability | 650,000 | 263,918 | ||
| Line of credit-Equity Line Of Credit | 0 | 80,000 | ||
| Notes payable, current portion-Quantum Notes | 351,307 | 3,248,000 | ||
| Notes payable, current portion-September2024Convertible Note | 0 | 2,094,000 | ||
| Loan payable, related party, net of discount-Related Party | - | 471,651 | ||
| Loan payable, related party, net of discount-Revolving Credit Facility | 471,651 | - | ||
| Line of credit-Revolving Credit Facility | 456,097 | 456,097 | ||
| Notes payable, net of discount-Related Party | 1,241,996 | - | ||
| Notes payable, net of discount | - | 433,983 | ||
| Notes payable, current portion-Exchange Notes | 0 | 1,499,000 | ||
| Common stock issuance obligation | 18,941 | 69,621 | ||
| Total current liabilities | 16,244,608 | 19,010,320 | ||
| Notes payable, less current portion, net of discount | 593,941 | 593,941 | ||
| Operating lease liabilities, less current portion | 2,910 | 269,338 | ||
| Deferred revenue, net of current portion | 0 | 69,999 | ||
| Deferred tax liabilities, net | 119,192 | 67,378 | ||
| Total liabilities | 16,960,651 | 20,010,976 | ||
| Preferred stock, 0.0001 par value, 10,000,000 shares authorized 1,788 and 6,158 shares issued and outstanding as of december 31, 2025, and december 31, 2024, respectively | 1 | 1 | ||
| Common stock, 0.0001 par value 100,000,000 shares authorized 33,193,140 and 16,297,190 shares issued and outstanding as of december 31, 2025, and 2024, respectively | 3,319 | 1,630 | ||
| Additional paid-in capital | 87,865,771 | 67,683,754 | ||
| Accumulated deficit | -82,416,723 | -67,703,873 | ||
| Total stockholders equity (deficit) | 5,452,368 | -18,488 | ||
| Total liabilities and stockholders equity (deficit) | 22,413,019 | 19,992,488 | ||
VSEE HEALTH, INC. (VSEE)
VSEE HEALTH, INC. (VSEE)